Ilsung Pharm (003120) — Free Cash Flow Generation Index
Ilsung Pharm (003120) has a Free Cash Flow Generation Index of 0.92x as of June 2025. Free cash flow of ₩4.73 Billion represents 1% of operating cash flow (₩5.13 Billion). Explore reinvestment intensity of Ilsung Pharm to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Ilsung Pharm Free Cash Flow Generation Index (2013–2025)
Historical FCF Generation Index trend for Ilsung Pharm across 9 annual periods. For the full cash flow conversion analysis, see how efficiently does Ilsung Pharm generate cash.
Annual Free Cash Flow Generation for Ilsung Pharm (2013–2025)
Year-by-year Free Cash Flow Generation Index for Ilsung Pharm. Check 003120 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.44x | ₩1.71 Billion | ₩3.88 Billion | ₩2.18 Billion | ▲ +136.3% |
| 2021 | -1.21x | ₩-6.91 Billion | ₩5.70 Billion | ₩10.93 Billion | ▲ +42.1% |
| 2020 | -2.09x | ₩-3.26 Billion | ₩1.56 Billion | ₩4.82 Billion | ▼ -391.8% |
| 2019 | 0.72x | ₩3.15 Billion | ₩4.39 Billion | ₩1.24 Billion | ▼ -21.3% |
| 2018 | 0.91x | ₩13.76 Billion | ₩15.09 Billion | ₩1.21 Billion | ▲ +11.5% |
| 2017 | 0.82x | ₩8.31 Billion | ₩10.16 Billion | ₩1.85 Billion | ▼ -44.4% |
| 2015 | 1.47x | ₩8.89 Billion | ₩6.04 Billion | ₩2.85 Billion | ▲ +20.1% |
| 2014 | 1.23x | ₩5.14 Billion | ₩4.19 Billion | ₩945.31 Million | ▲ +0.2% |
| 2013 | 1.22x | ₩6.19 Billion | ₩5.06 Billion | ₩1.13 Billion | — |